← SynDRA
SEVITERONEL
SynDRA canonical compound SYN0038012 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CYP17A1 |
|---|
| Mechanism of action | Cytochrome P450 inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Cytochrome P450 inhibitor
- CYP17A1 INHIBITOR
- Cytochrome P450 17A1 inhibitor
- AR ANTAGONIST
Drug classes
- Antineoplastic Agents
- Cytochrome P-450 Enzyme Inhibitors
Cross-references
Synonyms
- Vt-464
- INO-464
- CHEMBL3264610
- ZINC139920592
- AKOS030526607
- DB12275
- CS-3139
- HY-15996
- 1H-1,2,3-Triazole-5-methanol, alpha-(6,7-bis(difluoromethoxy)-2-naphthalenyl)-alpha-(1-methylethyl)-, (alphaS)-
- UNII-8S5OIN36X4 component ZBRAJOQFSNYJMF-SFHVURJKSA-N
- VT-464
- 8S5OIN36X4
- seviteronelum
- RefChem:182632
- DTXCID401509920
- UNII-8S5OIN36X4
- (S)-seviteronel
- C18H17F4N3O3
- SEVITERONEL [INN]
- SEVITERONEL [WHO-DD]
- orb1708246
- SCHEMBL23299702
- SCHEMBL29364397
- SCHEMBL29892874
- GTPL13855
- ZBRAJOQFSNYJMF-SFHVURJKSA-N
- GLXC-20370
- EX-A5986
- KPC53715
- MFCD28167778
- NSC783294
- NSC788846
- compound 6 [PMID: 24775307]
- NSC-783294
- NSC-788846
- SB17087
- NCGC00390672-01
- NCGC00390672-02
- DA-68639
Look up SEVITERONEL in the interactive SynDRA portal →